Advancing Parkinson’s Disease Diagnostics: The Potential of Arylpyrazolethiazole Derivatives for Imaging α‑Synuclein Aggregates

• Federica Bonanno,
• Ran Sing Saw,
• Daniel Bleher,
• Ioannis Papadopoulos,
• Gregory D. Bowden,
• Kaare Bjerregaard-Andersen,
• Albert D. Windhorst,
• Bernd J. Pichler,
• Kristina Herfert,
• Andreas Maurer

Affiliations

Federica Bonanno

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany

Ran Sing Saw

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany

Daniel Bleher

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany

Ioannis Papadopoulos

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany

Gregory D. Bowden

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany

Kaare Bjerregaard-Andersen

Department of Antibody Engineering and Biochemistry, H. Lundbeck A/S, Valby, Denmark

Albert D. Windhorst

Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Bernd J. Pichler

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany

Kristina Herfert

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany

Andreas Maurer

Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany